$0.4472
0.0511.60%
At close: -
$0.4700
0.025.10%
After Hours: 6:07 PM EDT
Comments
Loading...
Vaxart Analyst Ratings and Price Targets | NASDAQ:VXRT | Benzinga
Vaxart Inc has a consensus price target of $3.33 based on the ratings of 3 analysts. The high is $4 issued by Oppenheimer on August 15, 2024. The low is $2 issued by B. Riley Securities on March 27, 2025. The 3 most-recent analyst ratings were released by B. Riley Securities, Oppenheimer, and B. Riley Securities on March 27, 2025, August 15, 2024, and January 31, 2024, respectively. With an average price target of $2.67 between B. Riley Securities, Oppenheimer, and B. Riley Securities, there's an implied 467.38% upside for Vaxart Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B. Riley Securities
Oppenheimer
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Vaxart
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/27/2025 | Buy Now | 325.53% | B. Riley Securities | Mayank Mamtani70% | $2.5 → $2 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 751.06% | Oppenheimer | Cheng Li3% | → $4 | Initiates | → Outperform | Get Alert |
| 01/31/2024 | Buy Now | 325.53% | B. Riley Securities | Mayank Mamtani70% | → $2 | Upgrade | Neutral → Buy | Get Alert |
| 09/07/2023 | Buy Now | 751.06% | Cantor Fitzgerald | Charles Duncan68% | → $4 | Reiterates | Overweight → Overweight | Get Alert |
| 08/07/2023 | Buy Now | 751.06% | Cantor Fitzgerald | Charles Duncan68% | $6 → $4 | Maintains | Overweight | Get Alert |
| 12/19/2022 | Buy Now | 219.15% | B. Riley Securities | Mayank Mamtani70% | $6 → $1.5 | Maintains | Neutral | Get Alert |
| 09/02/2022 | Buy Now | 1602.13% | Cantor Fitzgerald | Charles Duncan68% | $11 → $8 | Maintains | Overweight | Get Alert |
| 05/19/2022 | Buy Now | 1176.6% | B. Riley Securities | Mayank Mamtani70% | $7 → $6 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Vaxart (VXRT) stock?
The latest price target for Vaxart (NASDAQ:VXRT) was reported by B. Riley Securities on March 27, 2025. The analyst firm set a price target for $2.00 expecting VXRT to rise to within 12 months (a possible 325.53% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vaxart (VXRT)?
The latest analyst rating for Vaxart (NASDAQ:VXRT) was provided by B. Riley Securities, and Vaxart maintained their buy rating.
When was the last upgrade for Vaxart (VXRT)?
The last upgrade for Vaxart Inc happened on January 31, 2024 when B. Riley Securities raised their price target to $2. B. Riley Securities previously had a neutral for Vaxart Inc.
When was the last downgrade for Vaxart (VXRT)?
There is no last downgrade for Vaxart.
When is the next analyst rating going to be posted or updated for Vaxart (VXRT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxart was filed on March 27, 2025 so you should expect the next rating to be made available sometime around March 27, 2026.
Is the Analyst Rating Vaxart (VXRT) correct?
While ratings are subjective and will change, the latest Vaxart (VXRT) rating was a maintained with a price target of $2.50 to $2.00. The current price Vaxart (VXRT) is trading at is $0.47, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
